| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.04B | 39.97B | 39.73B | 39.57B | 36.74B | 35.64B |
| Gross Profit | 12.08B | 11.99B | 12.07B | 11.61B | 10.73B | 10.04B |
| EBITDA | 3.19B | 3.36B | 3.66B | 3.40B | 2.56B | 2.22B |
| Net Income | 1.45B | 1.47B | 1.70B | 1.48B | 1.14B | 915.00M |
Balance Sheet | ||||||
| Total Assets | 53.18B | 53.24B | 54.08B | 50.76B | 49.38B | 47.52B |
| Cash, Cash Equivalents and Short-Term Investments | 14.15B | 14.18B | 11.20B | 12.12B | 12.34B | 11.53B |
| Total Debt | 1.09B | 1.08B | 1.19B | 668.00M | 691.00M | 697.00M |
| Total Liabilities | 15.92B | 15.72B | 16.91B | 16.51B | 16.13B | 15.23B |
| Stockholders Equity | 36.65B | 36.60B | 36.33B | 33.52B | 32.60B | 31.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.64B | 24.00M | 891.00M | 1.30B | 1.80B |
| Operating Cash Flow | 0.00 | 4.43B | 795.00M | 1.78B | 2.06B | 2.59B |
| Investing Cash Flow | 0.00 | -381.00M | -817.00M | -908.00M | -753.00M | -777.00M |
| Financing Cash Flow | 0.00 | -1.15B | -978.00M | -1.19B | -631.00M | -626.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.31B | 8.74 | ― | 3.67% | -3.74% | 3.99% | |
80 Outperform | ¥19.57B | 11.88 | ― | 3.06% | 0.27% | 7.57% | |
74 Outperform | ¥13.97B | 9.18 | ― | 2.81% | 0.23% | -8.64% | |
74 Outperform | ¥27.95B | 9.19 | ― | 7.72% | 8.01% | 13.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥20.45B | -6.87 | ― | 4.40% | -4.00% | -386.52% | |
52 Neutral | ¥19.22B | -6.25 | ― | 4.09% | 1.03% | -92.80% |
Fukuvi Chemical Industry Co., Ltd. has announced corrections to its previously released financial results for the three months ending June 30, 2025. The corrections were made due to errors identified in the quarterly consolidated balance sheet and related disclosures, impacting the company’s reported financial position.
Fukuvi Chemical Industry Co., Ltd. reported its consolidated financial results for the six months ending September 30, 2025, showing a slight decrease in net sales by 0.5% compared to the previous year. However, the company experienced significant growth in operating profit, ordinary profit, and profit attributable to owners of the parent, with increases of 13.3%, 25.5%, and 27.6% respectively. The equity-to-asset ratio improved to 70.1%, indicating a stronger financial position. The company also announced an increase in dividends, reflecting confidence in its financial stability and future prospects.